Axena Health, Mayo Clinic Team Up for Female Urinary Incontinence Education

Axena Health Inc. is collaborating with the Mayo Clinic to integrate the organization’s overactive bladder (OAB) educational content into the company’s Leva Pelvic Health System.

The Leva System is designed to provide women with a convenient, non-invasive option for treating urinary incontinence (UI) through a modern approach to supervised pelvic floor muscle training. The physician-prescribed program uniquely combines the U.S. Food and Drug Administration (FDA)-cleared Leva device and smartphone app to provide at-home guided treatment, personalized coaching, educational resources, and progress tracking. Mayo Clinic’s educational content on OAB will be available on the Leva app, further enhancing the Leva program’s comprehensive treatment offering.

“Urinary incontinence impacts millions of women worldwide yet remains underdiagnosed and undertreated due in part to a lack of discussion and education about the condition,” Axena Health CEO Randy Pritchard said. “Our collaboration with Mayo Clinic underscores our commitment to empowering women to take control of their pelvic health through clinically proven treatments and accessible, evidence-based education.”

The new content will complement the Leva app’s existing resources on UI and fecal incontinence so users can gain a deeper understanding of their condition, available treatments, and the importance of pelvic floor health. The content will be available to all Leva users beginning this spring.

“Education is a cornerstone of effective care, particularly for conditions like urinary incontinence where stigma and misinformation often hinder treatment,” Axena Health Chief Medical Officer Dr. Mandy Pulliam stated. “Integrating this important content allows us to provide users of the Leva System with trusted evidence-based information during their training sessions that complements their treatment journey.”

The collaboration includes an investment from Mayo Clinic to further Axena Health’s efforts in advancing women’s pelvic health, opening the door to future innovations, educational initiatives, and evidence-based treatments.

The Leva Pelvic Health System offers a non-invasive, medication-free way for women to treat urinary incontinence and chronic fecal incontinence (FI) at home in just five minutes a day. Combining a small FDA-cleared vaginal motion sensor with integrated software, the Leva System offers precise, real-time visualization of pelvic movement, progress tracking and active physician involvement, all of which support improved treatment outcomes. The Leva System is available by prescription only, enabling physician engagement in each patient’s success while also offering scalable first-line treatment of UI and chronic FI. The Leva System has multiple clinical trials and published data from globally recognized medical centers supporting its efficacy in treating UI, including two studies in Obstetrics and Gynecology, the official publication of the American College of Obstetricians and Gynecologists.

Axena Health Inc. aims to improve the lives of women with pelvic floor disorders. Axena Health’s flagship product, the Leva Pelvic Health System, offers a first-line treatment for UI and FI, underreported conditions affecting more than 78 million and 12 million women in the United States alone. Axena Health’s technology enables a modern approach to supervised pelvic floor muscle training via precise visualization of movement in real time, while monitoring usage and progress.